Information de reference pour ce titreAccession Number: | 00006565-201004000-00013.
|
Author: | Petruzella, Frank D. MD; Gorelick, Marc H. MD, MSCE
|
Institution: | Clinical Instructor (Petruzella), Professor (Gorelick), Division of Emergency Medicine, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI.
|
Title: | |
Source: | Pediatric Emergency Care. 26(4):302-307, April 2010.
|
Abstract: | Viral bronchiolitis is the most common cause of hospitalization among infants. Despite its prevalence, no consistently effective therapy has been found to date, providing the driving force behind much of the ongoing research into this illness. In this review, we present a summary of the most recent published trials of interventions for bronchiolitis. Included are studies evaluating bronchodilators, corticosteroids, positive pressure ventilation, as well as 3 newer therapies for bronchiolitis: heliox, mucolytics, and leukotriene receptor antagonists.
(C) 2010 Lippincott Williams & Wilkins, Inc.
|
Author Keywords: | bronchiolitis; bronchodilators; corticosteroids; bronchiolitis treatment.
|
References: | 1. Smyth RL, Openshaw PJ, Smyth Rosalind L, et al. Bronchiolitis. Lancet. 2006;368(9532):312-322.
2. Willson DF, Landrigan CP, Horn S, et al. Complications in infants hospitalized for bronchiolitis or respiratory syncytial virus pneumonia. J Pediatr. 2003;143(suppl 5):S142-S149.
3. Bush A, Thomson AH. Acute bronchiolitis. BMJ. 2007;335(7628):1037-1041.
4. American Academy of Pediatrics Subcommittee on Diagnosis, Management of Bronchiolitis. Diagnosis and management of bronchiolitis. Pediatrics. 2006;118(4):1774-1793.
5. Gadomski AM, Bhasale AL. Bronchodilators for bronchiolitis [update of Cochrane Database Syst Rev. 2000;(2):CD001266; PMID: 10796626]. Cochrane Database Syst Rev. 2006;3:CD001266.
6. Hartling L, Wiebe N, Russell K, et al. Epinephrine for bronchiolitis. Cochrane Database Syst Rev. 2004;(1):CD003123.
7. Hartling L, Wiebe N, Russell K, et al. A meta-analysis of randomized controlled trials evaluating the efficacy of epinephrine for the treatment of acute viral bronchiolitis. Arch Pediatr Adolesc Med. 2003;157(10):957-964.
8. King VJ, Viswanathan M, Bordley WC, et al. Pharmacologic treatment of bronchiolitis in infants and children: a systematic review. Arch Pediatr Adolesc Med. 2004;158(2):127-137.
9. Patel H, Gouin S, Platt RW, et al. Randomized, double-blind, placebo-controlled trial of oral albuterol in infants with mild-to-moderate acute viral bronchiolitis. J Pediatr. 2003;142(5):509-514.
10. Hariprakash S, Alexander J, Carroll W, et al. Randomized controlled trial of nebulized adrenaline in acute bronchiolitis. Pediatr Allergy Immunol. 2003;14(2):134-139.
11. Langley JM, Smith MB, LeBlanc JC, et al. Racemic epinephrine compared to salbutamol in hospitalized young children with bronchiolitis; a randomized controlled clinical trial [ISRCTN46561076]. BMC Pediatr. 2005;5(1):7.
12. Mull CC, Scarfone RJ, Ferri LR, et al. A randomized trial of nebulized epinephrine vs albuterol in the emergency department treatment of bronchiolitis. Arch Pediatr Adolesc Med. 2004;158(2):113-118.
13. Ralston S, Hartenberger C, Anaya T, et al. Randomized, placebo-controlled trial of albuterol and epinephrine at equipotent beta-2 agonist doses in acute bronchiolitis. Pediatr Pulmonol. 2005;40(4):292-299.
14. Wainwright C, Altamirano L, Cheney M, et al. A multicenter, randomized, double-blind, controlled trial of nebulized epinephrine in infants with acute bronchiolitis. N Engl J Med. 2003;349(1):27-35.
15. Walsh P, Caldwell J, McQuillan KK, et al. Comparison of nebulized epinephrine to albuterol in bronchiolitis. Acad Emerg Med. 2008;15(4):305-313.
16. Wohl ME, Chernick V. State of the art: bronchiolitis. Am Rev Respir Dis. 1978;118(4):759-781.
17. Barr FE, Patel NR, Newth CJ. The pharmacologic mechanism by which inhaled epinephrine reduces airway obstruction in respiratory syncytial virus-associated bronchiolitis. J Pediatr. 2000;136(5):699-700.
18. Rowe BH, Spooner C, Ducharme FM, et al. Early emergency department treatment of acute asthma with systemic corticosteroids [update in Cochrane Database Syst Rev. 2001;(1):CD002178; PMID: 11279756]. Cochrane Database Syst Rev. 2000;(2):CD002178.
19. Dabbous IA, Tkachyk JS, Stamm SJ. A double blind study on the effects of corticosteroids in the treatment of bronchiolitis. Pediatrics. 1966;37(3):477-484.
20. Corneli HM, Zorc JJ, Majahan P, et al. A multicenter, randomized, controlled trial of dexamethasone for bronchiolitis. N Engl J Med. 2007;357(4):331-339.
21. Patel H, Platt R, Lozano JM, et al. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev. 2004;(3):CD004878.
22. Blom D, Ermers M, Bont L, et al. Inhaled corticosteroids during acute bronchiolitis in the prevention of post-bronchiolitic wheezing. Cochrane Database Syst Rev. 2007;(1):CD004881.
23. Csonka P, Kaila M, Laippala P, et al. Oral prednisolone in the acute management of children age 6 to 35 months with viral respiratory infection-induced lower airway disease: a randomized, placebo-controlled trial. J Pediatr. 2003;143(6):725-730.
24. Zhang L, Ferruzzi E, Bonfanti T, et al. Long and short-term effect of prednisolone in hospitalized infants with acute bronchiolitis. J Paediatr Child Health. 2003;39(7):548-551.
25. Teeratakulpisarn J, Limwattananon C, Tanupattarachai S, et al. Efficacy of dexamethasone injection for acute bronchiolitis in hospitalized children: a randomized, double-blind, placebo-controlled trial. Pediatr Pulmonol. 2007;42(5):433-439.
26. Kuyucu S, Unal S, Kuyucu N, et al. Additive effects of dexamethasone in nebulized salbutamol or l-epinephrine treated infants with acute bronchiolitis. Pediatr Int. 2004;46(5):539-544.
27. Bentur L, Shoseyov D, Feigenbaum D, et al. Dexamethasone inhalations in RSV bronchiolitis: a double-blind, placebo-controlled study. Acta Paediatr. 2005;94(7):866-871.
28. LeLorier J, Gregoire G, Benhaddad A, et al. Discrepancies between meta-analyses and subsequent large randomized, controlled trials. N Engl J Med. 1997;337(8):536-542.
29. Bisgaard H, Study Group on Montelukast, Respiratory Syncytial Virus, Bisgaard Hans. A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis. Am J Respir Crit Care Med. 2003;167(3):379-383.
30. Boogaard R, Hulsmann AR, van Veen L, et al. Recombinant human deoxyribonuclease in infants with respiratory syncytial virus bronchiolitis. Chest. 2007;131(3):788-795.
31. Cambonie G, Milesi C, Fournier-Favre S, et al. Clinical effects of heliox administration for acute bronchiolitis in young infants. Chest. 2006;129(3):676-682.
32. Kuzik BA, Al-Qadhi SA, Kent S, et al. Nebulized hypertonic saline in the treatment of viral bronchiolitis in infants. J Pediatr. 2007;151(3):266-270.
33. Liet JM, Millotte B, Tucci M, et al. Noninvasive therapy with helium-oxygen for severe bronchiolitis. J Pediatr. 2005;147(6):812-817.
34. Mandelberg A, Tal G, Witzling M, et al. Nebulized 3% hypertonic saline solution treatment in hospitalized infants with viral bronchiolitis. Chest. 2003;123(2):481-487.
35. Martinon-Torres F, Rodriguez-Nunez A, Martinon-Sanchez JM, et al. Heliox therapy in infants with acute bronchiolitis. Pediatrics. 2002;109(1):68-73.
36. Martinon-Torres F, Rodriguez-Nunez A, Martinon-Sanchez JM, et al. Nasal continuous positive airway pressure with heliox in infants with acute bronchiolitis. Respir Med. 2006;100(8):1458-1462.
37. Merkus PJ, de Hoog M, van Gent R, et al. DNase treatment for atelectasis in infants with severe respiratory syncytial virus bronchiolitis. Eur Respir J. 2001;18(4):734-737.
38. Nasr SZ, Strouse PJ, Soskolne E, et al. Efficacy of recombinant human deoxyribonuclease I in the hospital management of respiratory syncytial virus bronchiolitis. Chest. 2001;120(1):203-208.
39. Thia LP, McKenzie SA, Blyth TP, et al. Randomised controlled trial of nasal continuous positive airways pressure (CPAP) in bronchiolitis. Arch Dis Child. 2008;93(1):45-47.
40. Reuben AD, Harris AR. Heliox for asthma in the emergency department: a review of the literature. Emerg Med J. 2004;21(2):131-135.
41. Tristram DA, Welliver RC. Bronchiolitis. In: Long SS, ed. Principles and Practice of Pediatric Infectious Diseases. 2nd ed. Philadelphia, PA: Churchill Livingstone; 2003:213-219.
42. Soong WJ, Hwang B, Tang RB. Continuous positive airway pressure by nasal prongs in bronchiolitis. Pediatr Pulmonol. 1993;16(3):163-166.
43. Beasley JM, Jones SE. Continuous positive airway pressure in bronchiolitis. Br Med J (Clin Res Ed). 1981;283(6305):1506-1508.
44. van Schaik SM, Welliver RC, Kimpen JL. Novel pathways in the pathogenesis of respiratory syncytial virus disease. Pediatr Pulmonol. 2000;30(2):131-138.
45. Da Dalt L, Callegaro S, Carraro S, et al. Nasal lavage leukotrienes in infants with RSV bronchiolitis. Pediatr Allergy Immunol. 2007;18(2):100-104.
46. Dimova-Yaneva D, Russell D, Main M, et al. Eosinophil activation and cysteinyl leukotriene production in infants with respiratory syncytial virus bronchiolitis. Clin Exp Allergy. 2004;34(4):555-558.
47. Oymar K, Halvorsen T, Aksnes L, et al. Mast cell activation and leukotriene secretion in wheezing infants. Relation to respiratory syncytial virus and outcome. Pediatr Allergy Immunol. 2006;17(1):37-42.
48. Sznajer Y, Westcott JY, Wenzel SE, et al. Airway eicosanoids in acute severe respiratory syncytial virus bronchiolitis. J Pediatr. 2004;145(1):115-118.
|
Language: | English.
|
Document Type: | CME Review Article.
|
Journal Subset: | Nursing. Clinical Medicine. Health Professions.
|
ISSN: | 0749-5161
|
NLM Journal Code: | pau, 8507560
|
DOI Number: | https://dx.doi.org/10.1097/PEC.0...- ouverture dans une nouvelle fenêtre
|
Annotation(s) | |
|
|